NCT07414732
Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors
Recruiting
NAAges 18–99InterventionalHealth servicesMassachusetts General HospitalInvestigator-initiated
~150 participants
Updated 2026-05-20 on ClinicalTrials.gov
What's tested:Savvy Medication Adherence Intervention
At a glance
Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Self-Reported Medication Adherence
Measured over 6 months
Conditions
NCT07414732
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Massachusetts General Hospital
Boston, Massachusettsstudy coordinator listed
Recruiting
Massachusetts General Hospital
Boston, Massachusettsno site contact published
Active, not recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Sanjula Singh, MD PhD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Self-Reported Medication Adherence6 months
The primary outcome is self-reported medication adherence using the validated Medication Adherence Report Scale (MARS-5). The MARS-5 scores ranges from 5-25; higher scores indicate better adherence.